One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS […]
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
Dr. Steven Victor, CEO of Intellicell, seems to have made two comments on a recent blog post I did on stem cell sports medicine (see below). Victor and Intellicell received a warning letter from the FDA in March 2012 with the FDA. I’m not aware of Intellicell publicly addressing the FDA issues. If you have, Intellicell, please
Dr. Steven Victor of Intellicell Comments on its Stem Cell Treatments Read More »
According to the international ranking service, Leiden Ranking, the USA comes out on top for high impact science. Out of their top Leiden Ranked 25 universities ranked by the percentage of papers in the top 10% of their respective fields for science overall, the USA had 22 of the top spots. MIT ranked first and
Leiden Ranking: USA does great science, but does not play well with others Read More »
After a couple of years blogging about stem cells here, I decided to direct some of my writing effort toward a book on stem cells. I started this project with the publisher last summer and I am happy to report that the book should be coming out later this year some time. I just sent
Writing the book on stem cells Read More »
Below are links to specific court documents and filings in stem cell-related legal proceedings. (I’ve also placed in parentheses links to my posts/analysis on these). Enjoy, especially you lawyers and investors. It’s a work in progress so expect more cases and documents to appear. In fact, if you have suggested additions please add them (plus
Your stem cell legal documents hub Read More »
Over the last few weeks, I have enjoyed talking with and interviewing Dr. Allan Wu, of The Morrow Institute on stem cell cosmetic procedures. I was impressed greatly by his talk at the World Stem Cell Summit last year. Dr. Wu is a fellowship trained Surgical Molecular Biologist with a background in Molecular Embryology and a board
Interview with Regenerative Surgeon, Dr. Allan Wu Read More »
It is always exciting when a biomedical technology as revolutionary as iPS cells is on the cusp of being used in patients for the first time. In the last few days stories have reported about how a proposed clinical trial based on iPS cells has completed several regulatory steps and is closer to starting. This
A big issue in the stem cell field is that firms increasingly are doing business in multiple countries. Associated with the increasingly international nature of the stem cell for-profit industry are emerging legal and ethical issues related to the transport of stem cell-based biological drugs across international borders. Think you can just FedEx human stem
RNL Bio has been accused of allegedly smuggling stem cells out of Korea to treat patients in Japan and China without going through customs. But there is more trouble. RNL Bio faces additional challenges as reportedly (AsiaOne News) the Korean Government is weighing whether to charge RNL criminally based on their stem cell treatments being illegal
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for
Stem Cell Person of the Year Finalists: time to vote Read More »